Atholl Management is a business strategy company that was founded in 1995. We have cross-functional experience that enables us to see the bigger picture. Our main interest is how value is created from innovation; on many levels, for inventors, for investors and for the broader community.

Atholl Client Examples
Business Strategy
Business plans and feasibility studies for more than 30 biotech, pharmaceutical, IT and manufacturing companies, universities and R&D Institutes.
Organisation Structure
Cell Therapies - biotech company
Inlogik - software company
CSIRO Centre for Groundwater Studies
Monash University School of Psychiatry & Psychology
Financial Strategy
University of Melbourne, Faculty of Medicine
State Library of Victoria
IT Strategy
The Victorian Arts Centre
Consumer Affairs Victoria
Commercialisation Strategy
National BioSecurity Centre
Malaysian Agricultural Research Institutes (MARDI)
Tianjin Institute for Pharmaceutical Research

Jim has over ten years experience in management consulting. His background includes five years as Director, Business Strategy at Ernst & Young, six years in large systems marketing and systems engineering at IBM, Business Manager of a Neurosciences R&D Centre and Chief Operating Officer of a venture capital funded software company.

Jim is a Founding Director of the BioMelbourne Network, Victoria's biotechnology industry association and a Director of the MonashLink Community Health Service.

Jim has delivered technology management and business strategy courses at Swinburne Graduate School of Management, the Singapore Economic Development Board and the IBM Asia Pacific Education Centre in Singapore. He has a Bachelor's Degree in Commerce, a Masters Degree in Innovation Management and a Graduate Diploma in Applied Finance.

Fabio has worked in research management with the CSIRO and spin-off biotech companies. He completed his PhD with the Istituto Nazionale Tumori di Milano, Italy. His scientific expertise is in drug development, particularly in cancer and immunology and has extensive European experience as well as Australian biotech experience.

Theresa has extensive marketing experience in China with multinational companies Bosch-Siemens and Samsung. Theresa divides her time between Melbourne and Shanghai. She has a double Masters Degree in Accounting and Marketing from RMIT and a Bachelor of Economics from Heilongjiang University.

1. April 2009
Jim Murray presented at the China 2009 Pharmaceutical R&D Summit in Shanghai on the topic of biotech business models and the globalisation of drug development.

2. March 2009
Atholl commences development of a cost of teaching model for the University of Melbourne's new graduate entry medical degree. This is the first time a comprehensive financial model of medical education has been developed and the results will be prepared for publication.

3. Atholl signs an agreement with the Tianjin Institute of Pharmaceutical Research to create a joint venture international drug development company. Commencing July 2008.

4. Jim Murray Appointed Acting CEO of the BioMelbourne Network. Jim has taken on the position from March to June 2008 while a replacement is found for Tim Murphy. Tim is now a Senior Advisor to Senator Kim Carr, the Federal Minister for Innovation, Industry, Science and Research.

5. Atholl Round Up - Download a newsletter updating Atholl’s recent activities. February 2008.

Update Archive